Dance-501 (Dance Biopharm)

N/A

Report date: 2024/08/01 20:00:04

Base Information

Drug NameDance-501 (Dance Biopharm)
Drug Alias NameInsulin inhalationDance 501 inhaled insulinDance-01Dance-501
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionPhosphokinases stimulantsOrnithine decarboxylase stimulants
TargetsPhosphokinasesOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAerami Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAerami Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A